First Prescription Weight-Loss Treatment Approved by FDA in 13 Years

NEW ERA BEGINS in the fight of obesity, long but worth fight.

Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese

-- First Prescription Weight-Loss Treatment Approved by FDA in 13 Years
-- Eisai to Launch BELVIQ in U.S. Following DEA's Completion of Scheduling Review

http://finance.yahoo.com/news/arena-pharmaceuticals-eisai-announce-fda-171300471.html